Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
PTMFusionNet: A Deep Learning Approach for Predicting Disease Related Post-translational Modification and Classifying
Jie Ni1, Yifan Zhou2, Bin Li2
1Institute for Molecular Medical Technology, State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China; Department of Medical Informatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, Jiangsu, China; Institute of Biomedical Devices (Suzhou), Southeast University, Suzhou, Jiangsu, China.
This study introduces PTMFusionNet, a deep learning tool that integrates protein expression and post-translational modification (PTM) data. It accurately classifies disease subtypes by predicting crucial PTM biomarkers.
Area of Science:
- Biochemistry and Bioinformatics
- Computational Biology
- Genomics and Proteomics
Background:
- Advanced mass spectrometry enables simultaneous detection of protein intensity and post-translational modification (PTM) data.
- Current PTM data integration with protein expression data is insufficient for comprehensive clinical applications.
- Accurate disease subtyping requires robust integration of multi-omics data.
Purpose of the Study:
- To develop a deep learning framework, PTMFusionNet, for predicting disease-related PTMs.
- To integrate predicted PTMs with protein expression data for enhanced disease subtyping.
- To improve the accuracy and robustness of disease classification using integrated proteomic and PTM data.
Main Methods:
- PTMFusionNet employs two Graph Convolutional Network (GCN) models: Layer-Attention GCN (LAGCN) for PTM potentiality scoring and Feature Weighting GCN (FWGCN) for data integration.
- LAGCN predicts the likelihood of specific PTMs occurring in disease contexts.
- FWGCN fuses PTM scores with protein expression data for classification tasks.
Main Results:
- PTMFusionNet demonstrated superior performance across three independent datasets (KIPAN, COADREAD, THCA).
- The model achieved higher accuracy, F1 score, and AUC compared to existing benchmark algorithms.
- Key PTM biomarkers relevant to disease subtyping were effectively identified.
Conclusions:
- PTMFusionNet offers a robust method for integrating PTM and protein expression data.
- The framework significantly advances disease subtyping by leveraging deep learning for multi-omics data analysis.
- This approach holds promise for improved clinical diagnosis and personalized treatment strategies.
More Related Videos
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025